Despoina Dimopoulou

Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

Antonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti et al. · Seminars in Arthritis and Rheumatism · 2018 · 77 citations

Life Sciences, Immunology, Pharmacotherapy +17

Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study

Despoina Dimopoulou, Maria Trachana, Polyxeni Pratsidou‐Gertsi et al. · Lara D. Veeken · 2017 · 35 citations · Full text

Medicine, Clinical Sciences, Orthopedics +15

Outcome of refractory to conventional and/or biologic treatment adult Still's disease following canakinumab treatment: Countrywide data in 50 patients

Katerina Laskari, Maria G. Tektonidou, Christina Katsiari et al. · Seminars in Arthritis and Rheumatism · 2020 · 29 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Long survival in a 69,XXX triploid infant in Greece.

Dimitrios Iliopoulos, Georgia Vassiliou, Eleni Sekerli et al. · PubMed · 2005 · 25 citations

Life Sciences, Genetics, Pediatrics +13

Investigation of juvenile idiopathic arthritis susceptibility loci: Results from a Greek population

Despoina Dimopoulou, Maria I. Zervou, Maria Trachana et al. · Human Immunology · 2013 · 21 citations

Life Sciences, Genetics, Immunology +14